Lan Hongxiang, Teeter Martha M, Gurevich Vsevolod V, Neve Kim A
Department of Physiology & Pharmacology, Oregon Health & Science University, Portland, Oregon, USA.
Mol Pharmacol. 2009 Jan;75(1):19-26. doi: 10.1124/mol.108.050542. Epub 2008 Sep 26.
Dopamine D(2) and D(3) receptors are similar subtypes with distinct interactions with arrestins; the D(3) receptor mediates less agonist-induced translocation of arrestins than the D(2) receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intracellular domain (IC2) of the D(2) and D(3) receptors to identify residues that contribute to the differential binding of arrestin to the subtypes. Arrestin 3 bound to glutathione transferase (GST) fusion proteins of the D(2) receptor IC2 more avidly than to the D(3) receptor IC2. Mutagenesis of the fusion proteins identified a residue at the C terminus of IC2, Lys149, that was important for the preferential binding of arrestin 3 to D(2)-IC2; arrestin binding to D(2)-IC2-K149C was greatly decreased compared with wild-type D(2)-IC2, whereas binding to the reciprocal mutant D(3)-IC2-C147K was enhanced compared with wild-type D(3)-IC2. Mutating this lysine in the full-length D(2) receptor to cysteine decreased the ability of the D(2) receptor to mediate agonist-induced arrestin 3 translocation to the membrane and decreased agonist-induced receptor internalization in human embryonic kidney 293 cells. The reciprocal mutation in the D(3) receptor increased receptor-mediated translocation of arrestin 3 without affecting agonist-induced receptor internalization. G protein-coupled receptor crystal structures suggest that Lys149, at the junction of IC2 and the fourth membrane-spanning helix, has intramolecular interactions that contribute to maintaining an inactive receptor state. It is suggested that the preferential agonist-induced binding of arrestin3 to the D(2) receptor over the D(3) receptor is due in part to Lys149, which could be exposed as a result of receptor activation.
多巴胺D(2)和D(3)受体是相似的亚型,与抑制蛋白有着不同的相互作用;D(3)受体介导的激动剂诱导的抑制蛋白易位比D(2)受体少。本研究的目的是比较D(2)和D(3)受体第二细胞内结构域(IC2)中未磷酸化的抑制蛋白结合决定因素,以确定导致抑制蛋白与这些亚型差异结合的残基。抑制蛋白3与D(2)受体IC2的谷胱甘肽S-转移酶(GST)融合蛋白的结合比与D(3)受体IC2的结合更紧密。融合蛋白的诱变鉴定出IC2 C末端的一个残基Lys149,它对于抑制蛋白3优先结合D(2)-IC2很重要;与野生型D(2)-IC2相比,抑制蛋白与D(2)-IC2-K149C的结合大大减少,而与反向突变体D(3)-IC2-C147K的结合相比野生型D(3)-IC2增强。将全长D(2)受体中的这个赖氨酸突变为半胱氨酸会降低D(2)受体介导激动剂诱导的抑制蛋白3向膜易位的能力,并降低人胚肾293细胞中激动剂诱导的受体内化。D(3)受体中的反向突变增加了受体介导的抑制蛋白3易位,而不影响激动剂诱导的受体内化。G蛋白偶联受体晶体结构表明,位于IC2和第四跨膜螺旋交界处的Lys149具有分子内相互作用,有助于维持受体的无活性状态。提示激动剂诱导的抑制蛋白3优先结合D(2)受体而非D(3)受体部分归因于Lys149,它可能因受体激活而暴露。